NEJM Evidence and CIDRAP announce Public Health Alerts
Peer-Reviewed Publication
Updates every hour. Last Updated: 17-Dec-2025 14:22 ET (17-Dec-2025 19:22 GMT/UTC)
A new series for the rapid communication of important public health data
A new study published in the Journal of Sports Economics finds that the legalization of sports betting in the United States is associated with significant increases in violent and impulsive crime during and immediately after major professional sporting events. Analyzing incident-level crime data from 2017 to 2021, researchers examined crime patterns from the start of a game through four hours after its conclusion across the NFL, NBA, MLB and NHL.
The study finds that states that legalized sports betting following the U.S. Supreme Court’s 2018 decision in Murphy v. NCAA experienced increases in assaults, larceny and vehicle theft on game days, with crime rising by roughly 30–70% depending on game context. The largest spikes occurred after home games and when outcomes defied betting expectations, such as when underdogs won.
Importantly, the researchers also identify spillover effects: increases in crime were observed in neighboring states even when those states had not legalized sports betting, suggesting bettors may cross state lines to place wagers and bring associated stress back home.
The findings further suggest a shift in the mechanisms driving betting-related aggression following the COVID-19 pandemic. While earlier increases in crime were primarily linked to financial losses, more recent evidence points to non-financial factors, including heightened emotional stress during close, unpredictable or overtime games.
The study highlights potential social costs associated with the rapid expansion of legal sports betting and underscores the importance of considering public safety and consumer protections alongside revenue generation as more states weigh legalization.
Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has successfully developed a nasal (intranasal) antiviral platform using AI technology to overcome the existing limitations of interferon-lambda treatments—namely, being "weak against heat and disappearing quickly from the nasal mucosa."
KAIST announced on December 15th that a joint research team—consisting of Professor Ho Min Ktim and Professor Hyun Jung Chung from the Department of Biological Sciences, and Professor Ji Eun Oh from the Graduate School of Medical Science and Engineering used AI to stably redesign the interferon-lambda protein and combined it with a delivery technology that ensures effective diffusion and long-term retention in the nasal mucosa, thereby implementing a universal prevention technology for various respiratory viruses.
COVID-19 does not just affect the respiratory system, but also significantly alters the brain in people who have fully recovered from the infectious disease, highlighting the long-term neurological impact of the virus.
Australian scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection.
Pregnant people who received a COVID-19 vaccine were far less likely to experience severe illness or deliver their babies prematurely, according to a major new UBC-led study published in JAMA. Drawing on data from nearly 20,000 pregnancies across Canada, the research found that vaccination was strongly associated with lower risks of hospitalization, intensive care admission and preterm birth. These benefits persisted as the virus evolved from the Delta variant to Omicron, which has evolved into newer sublineages that still dominate today.
A University of Maryland, Baltimore County (UMBC) study, published in Nature Communications, uncovers how enteroviruses—including those causing polio, myocarditis, encephalitis, and the common cold—hijack host cell machinery to replicate. Researchers determined the structure of a cloverleaf-shaped RNA element in the viral genome bound to the viral protein 3CD, which recruits host factors to form the viral replication complex. 3CD also acts as a switch between genome copying and protein synthesis. This highly conserved mechanism across all seven enteroviruses in the study presents a stable target for developing broad-spectrum antiviral drugs that could disrupt this essential interaction and prevent replication.